NCT03289858View on ClinicalTrials.gov

Randomized Controlled Trial for Exparel Hip Fracture

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

January 1, 2019

Study Completion Date

January 22, 2019

Conditions
Hip Fractures
Interventions
DRUG

Exparel

Subcutaneous injection at conclusion of surgical fixation of hip fracture

DRUG

Sodium Chloride

Saline Injection

Trial Locations (2)

40536

University of Kentucky, Lexington

01655

UMass Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

Orthopaedic Trauma Association

OTHER

collaborator

University of Kentucky

OTHER

lead

University of Massachusetts, Worcester

OTHER

NCT03289858 - Randomized Controlled Trial for Exparel Hip Fracture | Biotech Hunter | Biotech Hunter